<i>Pseudomonas aeruginosa</i>: A Bacterial Platform for Biopharmaceutical Production

<i>Pseudomonas aeruginosa</i> is a metabolically versatile opportunistic pathogen capable of surviving in a range of environments. The major contribution to these abilities relies on virulence factor production, e.g., exotoxins, phenazines, and rhamnolipids, regulated through a hierarchi...

Full description

Saved in:
Bibliographic Details
Main Authors: Doumit Camilios-Neto, Rodolfo Ricken do Nascimento, Jonathan Ratko, Nicole Caldas Pan, Rubia Casagrande, Waldiceu A. Verri, Josiane A. Vignoli
Format: Article
Language:English
Published: MDPI AG 2024-12-01
Series:Future Pharmacology
Subjects:
Online Access:https://www.mdpi.com/2673-9879/4/4/47
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850042099436617728
author Doumit Camilios-Neto
Rodolfo Ricken do Nascimento
Jonathan Ratko
Nicole Caldas Pan
Rubia Casagrande
Waldiceu A. Verri
Josiane A. Vignoli
author_facet Doumit Camilios-Neto
Rodolfo Ricken do Nascimento
Jonathan Ratko
Nicole Caldas Pan
Rubia Casagrande
Waldiceu A. Verri
Josiane A. Vignoli
author_sort Doumit Camilios-Neto
collection DOAJ
description <i>Pseudomonas aeruginosa</i> is a metabolically versatile opportunistic pathogen capable of surviving in a range of environments. The major contribution to these abilities relies on virulence factor production, e.g., exotoxins, phenazines, and rhamnolipids, regulated through a hierarchical system of communication, named quorum sensing (QS). QS involves the production, release, and recognition of two classes of diffusible signal molecules: N-acyl-homoserine lactones and alkyl-quinolones. These present a central role during <i>P. aeruginosa</i> infection, regulating bacterial virulence and the modulation of the host immune system. The influence of this arsenal of virulence factors on bacterial–host interaction makes <i>P. aeruginosa</i> a highly potential platform for the development of biopharmaceuticals. Here, we comprehensively reviewed the therapeutical applications of <i>P. aeruginosa</i> virulence factors and quorum sensing signaling molecules on pathological conditions, ranging from infections and inflammation to cancer disease.
format Article
id doaj-art-03a0252b336d4d65bed28ddb7d588ffc
institution DOAJ
issn 2673-9879
language English
publishDate 2024-12-01
publisher MDPI AG
record_format Article
series Future Pharmacology
spelling doaj-art-03a0252b336d4d65bed28ddb7d588ffc2025-08-20T02:55:38ZengMDPI AGFuture Pharmacology2673-98792024-12-014489291810.3390/futurepharmacol4040047<i>Pseudomonas aeruginosa</i>: A Bacterial Platform for Biopharmaceutical ProductionDoumit Camilios-Neto0Rodolfo Ricken do Nascimento1Jonathan Ratko2Nicole Caldas Pan3Rubia Casagrande4Waldiceu A. Verri5Josiane A. Vignoli6Departamento de Bioquímica e Biotecnologia, Centro de Ciências Exatas, Universidade Estadual de Londrina, Londrina 86057-970, BrazilDepartamento de Bioquímica e Biotecnologia, Centro de Ciências Exatas, Universidade Estadual de Londrina, Londrina 86057-970, BrazilDepartamento de Bioquímica e Biotecnologia, Centro de Ciências Exatas, Universidade Estadual de Londrina, Londrina 86057-970, BrazilDepartamento de Bioquímica e Biotecnologia, Centro de Ciências Exatas, Universidade Estadual de Londrina, Londrina 86057-970, BrazilDepartamento de Ciências Farmacêuticas, Centro de Ciências da Saúde, Universidade Estadual de Londrina, Londrina 86057-970, BrazilDepartamento de Imunologia, Parasitologia e Patologia Geral, Centro de Ciências Biológicas, Universidade Estadual de Londrina, Londrina 86057-970, BrazilDepartamento de Bioquímica e Biotecnologia, Centro de Ciências Exatas, Universidade Estadual de Londrina, Londrina 86057-970, Brazil<i>Pseudomonas aeruginosa</i> is a metabolically versatile opportunistic pathogen capable of surviving in a range of environments. The major contribution to these abilities relies on virulence factor production, e.g., exotoxins, phenazines, and rhamnolipids, regulated through a hierarchical system of communication, named quorum sensing (QS). QS involves the production, release, and recognition of two classes of diffusible signal molecules: N-acyl-homoserine lactones and alkyl-quinolones. These present a central role during <i>P. aeruginosa</i> infection, regulating bacterial virulence and the modulation of the host immune system. The influence of this arsenal of virulence factors on bacterial–host interaction makes <i>P. aeruginosa</i> a highly potential platform for the development of biopharmaceuticals. Here, we comprehensively reviewed the therapeutical applications of <i>P. aeruginosa</i> virulence factors and quorum sensing signaling molecules on pathological conditions, ranging from infections and inflammation to cancer disease.https://www.mdpi.com/2673-9879/4/4/47rhamnolipidsphenazinesquorum sensingvirulence factorsbiological drugs
spellingShingle Doumit Camilios-Neto
Rodolfo Ricken do Nascimento
Jonathan Ratko
Nicole Caldas Pan
Rubia Casagrande
Waldiceu A. Verri
Josiane A. Vignoli
<i>Pseudomonas aeruginosa</i>: A Bacterial Platform for Biopharmaceutical Production
Future Pharmacology
rhamnolipids
phenazines
quorum sensing
virulence factors
biological drugs
title <i>Pseudomonas aeruginosa</i>: A Bacterial Platform for Biopharmaceutical Production
title_full <i>Pseudomonas aeruginosa</i>: A Bacterial Platform for Biopharmaceutical Production
title_fullStr <i>Pseudomonas aeruginosa</i>: A Bacterial Platform for Biopharmaceutical Production
title_full_unstemmed <i>Pseudomonas aeruginosa</i>: A Bacterial Platform for Biopharmaceutical Production
title_short <i>Pseudomonas aeruginosa</i>: A Bacterial Platform for Biopharmaceutical Production
title_sort i pseudomonas aeruginosa i a bacterial platform for biopharmaceutical production
topic rhamnolipids
phenazines
quorum sensing
virulence factors
biological drugs
url https://www.mdpi.com/2673-9879/4/4/47
work_keys_str_mv AT doumitcamiliosneto ipseudomonasaeruginosaiabacterialplatformforbiopharmaceuticalproduction
AT rodolforickendonascimento ipseudomonasaeruginosaiabacterialplatformforbiopharmaceuticalproduction
AT jonathanratko ipseudomonasaeruginosaiabacterialplatformforbiopharmaceuticalproduction
AT nicolecaldaspan ipseudomonasaeruginosaiabacterialplatformforbiopharmaceuticalproduction
AT rubiacasagrande ipseudomonasaeruginosaiabacterialplatformforbiopharmaceuticalproduction
AT waldiceuaverri ipseudomonasaeruginosaiabacterialplatformforbiopharmaceuticalproduction
AT josianeavignoli ipseudomonasaeruginosaiabacterialplatformforbiopharmaceuticalproduction